How many drugs treat Malignant tumor of colon?

Drug Landscape tracks 5 marketed treatments for Malignant tumor of colon (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/malignant-tumor-of-colon.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Malignant tumor of colon — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Malignant tumor of colon (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Malignant tumor of colon, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Lonsurf	TIPIRACIL	Taiho Oncology Inc	Nucleoside Analog Antiviral [EPC]	Thymidine phosphorylase	2015-01-01
Erbitux	cetuximab	Imclone	Epidermal Growth Factor Receptor Antagonist [EPC]	Epidermal growth factor receptor	2004-01-01
Carac	5-fu	Spectrum Pharms	Nucleoside Metabolic Inhibitor	Aromatase	1962-01-01
Carac	fluorouracil	Extrovis	Nucleoside Metabolic Inhibitor [EPC]	Aromatase	1962-01-01
Erbitux	Erbitux	Hellenic Oncology Research Group		Epidermal growth factor receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Malignant tumor of colon
Extrovis · 1 drug in Malignant tumor of colon
Hellenic Oncology Research Group · 1 drug in Malignant tumor of colon
Imclone · 1 drug in Malignant tumor of colon
Spectrum Pharms · 1 drug in Malignant tumor of colon
Taiho Oncology Inc · 1 drug in Malignant tumor of colon

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Malignant tumor of colon:

Cite this brief

Drug Landscape (2026). Malignant tumor of colon — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/malignant-tumor-of-colon. Accessed 2026-06-10.

Malignant tumor of colon full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing